Cubicin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Imipenem, Cilastatin Sodium, and Relebactam Monohydrate for the Treatment of Cancer Patients With Febrile Neutropenia
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Malignant Solid Neoplasm Interventions:   Drug: Cefepime;   Drug: Imipenem/cilastatin-relebactam;   Drug: Daptomycin;   Drug: Linezolid;   Drug: Meropenem;   Drug: Piperacillin-Tazobactam;   Drug: Vancomycin Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2021 Category: Research Source Type: clinical trials